HBV Mutation Detail Information

> T115A Search Result


Mutation Information
Mutation Site T115A
Mutation Type Amino acid level
Gene/Protein/Region Type S
Relevant Drug lamivudine (LAM)
Literature Information
PubMed PMID 16928212
Disease Chronic hepatitis B
Published Year 2006
Journal Journal of gastroenterology and hepatology
Title Association of core promoter mutations with viral breakthrough in chronic hepatitis B patients on long-term lamivudine therapy.
Author Kazim SN,Chauhan R,Das BC,Sarin SK
Evidence Apart from the YMDD mutation, other lamivudine associated mutations of the polymerase gene resulted in S207R (Fig.2f) in two patients, F220L (Fig.2h) and C221G (Fig.2h) in one patient, S193L (Fig.2c) in one patient, W182Stop (Fig.2b) and F219S (Fig.2g) in one patient, E164D (Fig.2a) in two patients and T115A in one patient within the HBsAg.

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation